AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,063 | -19.7% | 3,483 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $33,716 | -11.7% | 3,483 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $38,174 | +153.7% | 3,483 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $15,047 | -42.1% | 3,483 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | -23.5% | 3,483 | +3.2% | 0.00% | -50.0% |
| Q2 2022 | $34,000 | -19.0% | 3,375 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $42,000 | -41.7% | 3,355 | +6.2% | 0.00% | -33.3% |
| Q4 2021 | $72,000 | +5.9% | 3,159 | +2.2% | 0.00% | -25.0% |
| Q3 2021 | $68,000 | +70.0% | 3,091 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $40,000 | +25.0% | 3,091 | +25.3% | 0.00% | 0.0% |
| Q1 2021 | $32,000 | +14.3% | 2,466 | +20.3% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | +21.7% | 2,050 | +32.3% | 0.00% | 0.0% |
| Q3 2020 | $23,000 | +91.7% | 1,550 | +106.7% | 0.00% | +100.0% |
| Q2 2020 | $12,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |